Prevention and control of noncommunicable diseases: lessons from the HIV experience

Global noncommunicable diseases--lessons from the HIV-AIDS experience.

T ubiquity and impact of non­ communicable diseases such as cardiovascular diseases, type 2 diabetes, cancers, chronic obstruc­ tive pulmonary disease, and psy­ chiatric disorders present major global health, development, and societal challenges.1 Acknowledg­ ing this fact, the United Nations (UN) General Assembly will hold a high­level meeting on global noncommunicable diseases on September 19...

Prevention and Control of Noncommunicable Diseases

HIV and noncommunicable diseases: the Asian perspective.

Asia is seeing a rise in noncommunicable diseases in their general population and among people living with HIV. Many Asians have low body weight, which can lead to higher plasma concentrations of antiretrovirals and, as a result, their toxicities. Examples are metabolic complications from protease inhibitors, chronic kidney disease from tenofovir, and hepatotoxicity from nevirapine. Asia has no...

Technology contribution to prevention of noncommunicable diseases.

Preliminary evaluation of the WHO global coordination mechanism on the prevention and control of noncommunicable diseases

1. Further to resolution WHA66.10 (2013), the Director-General developed draft terms of reference for a global coordination mechanism on the prevention and control of noncommunicable diseases, aimed at facilitating engagement among Member States, United Nations funds, programmes and agencies and other international partners, and non-State actors. The draft terms of reference were endorsed at th...